Japan’s PDMA Shifts Post-heparin Focus Of GMP Inspections Onto Asia
This article was originally published in PharmAsia News
Executive Summary
Japan's Pharmaceutical and Medical Device Agency will focus inspections for compliance with good manufacturing practices predominantly on Asian countries, the agency's inspection specialist, Ryoko Naruse, said during an Osaka seminar